A Study of EOC237 in Patients With Advanced Solid Tumor

Clinical trial NCT05895825 · RECRUITING

Trial details

NCT number: NCT05895825
Sponsor: Shanghai Yiteng Jingang Bio-pharmaceutical Technology Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2023-07-26
Primary completion: 2026-04-30
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.